Geopolitics Alpha

8-K - NovoCure Ltd (0001645113) (Filer)

Published . Updated .

GEOPOLITICS ALPHA8-K - NovoCure Ltd (0001645113)(Filer)NVCRGEOPOLITICS ALPHA

8-K - NovoCure filed an 8-K with the SEC on Oct 29 (a notice of a material company event).

Directly affected

  • NVCR NovoCure

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that NovoCure belongs to, so it often moves with news about it.

  • SYK Stryker+6.3% 30d

    Stryker is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • MMM 3M+2.4% 30d

    3M is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • BSX Boston Scientific-4.0% 30d

    Boston Scientific is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • BDX Becton, Dickinson and+6.6% 30d

    Becton, Dickinson and is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

  • MDLN Medline-12.3% 12d

    Medline is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
NVCR+6.79%+1.84%base-7.28%-7.11%after closeafter close
XLVNo price data for this ticker———————
SYKNo price data for this ticker———————
MMMNo price data for this ticker———————
BSXNo price data for this ticker———————
BDXNo price data for this ticker———————
MDLNNo price data for this ticker———————

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Filed: 2026-10-29 AccNo: 0001645113-26-000081 Size: 366 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

NovoCure (NVCR) since this story, compared with the market

CompanyWhenMoveStatus
NovoCure (NVCR)that day-7.28%final price
NovoCure (NVCR)the next day-7.11%final price
NovoCure (NVCR)three days earlier+1.84%final price
NovoCure (NVCR)five days earlier+6.79%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who is named in “8-K - NovoCure Ltd (0001645113) (Filer)”

Companies tied to this story

  • NVCR NovoCure

    For “8-K - NovoCure Ltd (0001645113) (Filer),” NovoCure (NVCR) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> NVCR

How “8-K - NovoCure Ltd (0001645113) (Filer)” reaches NovoCure (NVCR)

On 29 Oct 2026, “8-K - NovoCure Ltd (0001645113) (Filer)” is the story that connects NovoCure (NVCR) to this story.

The link for NovoCure (NVCR) is this: SEC 8-K filing -> direct issuer disclosure -> NVCR

Dates and price levels for NovoCure (NVCR)

NVCR traded between 11.91 and 13.85 across 2 sessions. The latest close on file is 13.13.

A simple score for NovoCure (NVCR)

14 out of 100

“8-K - NovoCure Ltd (0001645113) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.